Javascript must be enabled to continue!
The effect of Shen Fu injection on the NT-ProBNP in treatment heart failure patients
View through CrossRef
Objectives
to observe the effect of shen fu injection on the NT-ProBNP in the treatment of heart failure patients, and explore the efficacy of herbal injection on cardiac function in the treatment of heart failure.
Methods
According to patient history, clinical manifestations of heart failure, ultrasound results, 80 patients diagnosed as heart failure were selected. The patients were randomly divided into two groups: treatment group (A group, n=40) and control group (B group, n=40). Both groups received routine treatment such as cardiac (or heart) stimulants, nitrate and diuretic agent. ‘A’ group received shen fu injection 60 ml added to 150 ml saline water through intravenous drip infusion once a day, for 7–10 days. NT-ProBNP were measured in both group before and after treatment.
Results
There was statistical difference in A group before (2145±798 pg/ml) and after treatment (1232±563 pg/ml) (p<0.05). There was statistical difference in A group before (2152±769 pg/ml) and after treatment (1528±647 pg/ml) (p<0.05). There was statistical difference between A group (1232±563 pg/ml) and B group (1528±647 pg/ml) after treatment (p<0.05). There was statistical difference between A group (1232±563 pg/ml) and B group (1528±647 pg/ml) after treatment (p<0.05). The baseline of NT-ProBNP in both groups was consistent. The improvement of NT-ProBNP in A group is better than B group. NYHA functional class and ejection fraction (EF) in A group were improved better than B group.
Conclusion
Routine treatment (including cardiac inotropes, nitrates and diuretic agent) combined with shen fu infusion could lower the NT-ProBNP, and improve the cardiac function classification, ejection fraction and NYHA functional class. The study suggests that the combination of traditional Chinese medicine and Western medicine may produce further improvement in treatment heart failure patient.
Title: The effect of Shen Fu injection on the NT-ProBNP in treatment heart failure patients
Description:
Objectives
to observe the effect of shen fu injection on the NT-ProBNP in the treatment of heart failure patients, and explore the efficacy of herbal injection on cardiac function in the treatment of heart failure.
Methods
According to patient history, clinical manifestations of heart failure, ultrasound results, 80 patients diagnosed as heart failure were selected.
The patients were randomly divided into two groups: treatment group (A group, n=40) and control group (B group, n=40).
Both groups received routine treatment such as cardiac (or heart) stimulants, nitrate and diuretic agent.
‘A’ group received shen fu injection 60 ml added to 150 ml saline water through intravenous drip infusion once a day, for 7–10 days.
NT-ProBNP were measured in both group before and after treatment.
Results
There was statistical difference in A group before (2145±798 pg/ml) and after treatment (1232±563 pg/ml) (p<0.
05).
There was statistical difference in A group before (2152±769 pg/ml) and after treatment (1528±647 pg/ml) (p<0.
05).
There was statistical difference between A group (1232±563 pg/ml) and B group (1528±647 pg/ml) after treatment (p<0.
05).
There was statistical difference between A group (1232±563 pg/ml) and B group (1528±647 pg/ml) after treatment (p<0.
05).
The baseline of NT-ProBNP in both groups was consistent.
The improvement of NT-ProBNP in A group is better than B group.
NYHA functional class and ejection fraction (EF) in A group were improved better than B group.
Conclusion
Routine treatment (including cardiac inotropes, nitrates and diuretic agent) combined with shen fu infusion could lower the NT-ProBNP, and improve the cardiac function classification, ejection fraction and NYHA functional class.
The study suggests that the combination of traditional Chinese medicine and Western medicine may produce further improvement in treatment heart failure patient.
Related Results
PROGNOSTIC VALUE OF NT-PROBNP COMPLEMENTS THE GEACE SCORE IN PEOPLE WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME
PROGNOSTIC VALUE OF NT-PROBNP COMPLEMENTS THE GEACE SCORE IN PEOPLE WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME
Objectives
This study was designed to investigate whether admission N-terminal pro-brain natriuretic peptide (NT-proBNP) increase the prognostic accuracy of Globa...
THE REASEARCH INTO THE CLINICAL CHARACTERISTICS OF PERIPARTUM CARDIOMYOPATHY
THE REASEARCH INTO THE CLINICAL CHARACTERISTICS OF PERIPARTUM CARDIOMYOPATHY
Objectives
The research is to find the related risk factors that may lead to PPCM through analysing and summarising the general clinical characteristics of PPCM p...
Clinical impact of the determination of natriuretic peptides on long-term follow-up of patients treated in the Heart Failure Unit
Clinical impact of the determination of natriuretic peptides on long-term follow-up of patients treated in the Heart Failure Unit
Abstract
Introduction
The use of natriuretic peptides has spread in recent years as a diagnostic tool in patients with heart fai...
Diagnostic value and risk correlation of serum heart-type fatty acid-binding protein (H-FABP) and osteoprotegerin (OPG) in chronic heart failure
Diagnostic value and risk correlation of serum heart-type fatty acid-binding protein (H-FABP) and osteoprotegerin (OPG) in chronic heart failure
Background: To analyse the value of H-FABP and OPG in determining the severity of heart function in those suffering from long-term heart failure. Methods: A total of 196 patients w...
Plasmatic NT-proBNP is strongly associated with atrial fibrillation in patients with Implantable cardioverter defibrillator
Plasmatic NT-proBNP is strongly associated with atrial fibrillation in patients with Implantable cardioverter defibrillator
Abstract
Background and objectives
Atrial fibrillation is common in patients with chronic heart failure and associated with poor...
CORRELATION BETWEEN NT-PROBNP AND ECHOCARDIOGRAPHIC PARAMETERS IN PATIENTS WITH ARRHYTHMIAS
CORRELATION BETWEEN NT-PROBNP AND ECHOCARDIOGRAPHIC PARAMETERS IN PATIENTS WITH ARRHYTHMIAS
Background: Arrhythmias are a significant public health burden, associated with increased morbidity and mortality. NT-proBNP, a biomarker of cardiac stress, has been shown to be el...
MO722: Cardiac Biomarkers (NT-proBNP, Troponin I) and Heart Failure in Haemodialysis Patients
MO722: Cardiac Biomarkers (NT-proBNP, Troponin I) and Heart Failure in Haemodialysis Patients
Abstract
BACKGROUND AND AIMS
Patients with chronic kidney disease (CKD) stage 5 on haemodialysis are at a high risk of cardiovas...
PROGNOSTIC VALUE OF CIRCULATING CATESTATIN LEVELS ON HOSPITALISED PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
PROGNOSTIC VALUE OF CIRCULATING CATESTATIN LEVELS ON HOSPITALISED PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
Objectives
To evaluate prognostic value of circulating catestatin (CST) on hospitalised patients with acute myocardial infarction.
...

